AHSG and Obesity: These findings might serve information about fetuin-A and RBP4 as a prognostic factor for elevated cardiovascular risk in obesity and may help to define the therapeutic strategies and to find novel treatment options to alter lipoprotein levels and to reduce the risk of atherogenesis in obese subjects.